Key facts
- This page summarizes Valor IV Pharma Holdings, LLC's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2025, 17:45.
Valor IV Pharma Holdings, LLC - 28 Aug 2025 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- HRMY
- Reported as of
- 28 Aug 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Sep 2025, 17:45:59 UTC
- Prior SEC filing
- 05 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- Valor IV Pharma Holdings, LLC By: /s/ Antonio Gracias, Sole Manager
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Valor IV Pharma Holdings, LLC filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 02 Sep 2025.
Change
- Previous filing in this sequence was filed on 05 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (9)
CIK 0001821186
Primary reporting owner
Valor IV Pharma Holdings, LLC
- Relationship
- 10%+ Owner
- Address
- 320 N. SANGAMON, SUITE 1200, CHICAGO
- Signature
- Valor IV Pharma Holdings, LLC By: /s/ Antonio Gracias, Sole Manager
- Signature date
- 02 Sep 2025
CIK 0001822428
Valor Management L.P.
- Relationship
- 10%+ Owner
- Address
- 320 N. SANGAMON, SUITE 1200, CHICAGO
- Signature
- Valor Management L.P. By: /s/ Antonio Gracias, CEO
- Signature date
- 02 Sep 2025
CIK 0001821936
Valor Equity Capital IV LLC
- Relationship
- 10%+ Owner
- Address
- 320 N. SANGAMON, SUITE 1200, CHICAGO
- Signature
- Valor Equity Capital IV LLC By: Valor Management L.P., its managing member By: /s/ Antonio Gracias, CEO
- Signature date
- 02 Sep 2025
CIK 0001822427
Valor Equity Associates IV L.P.
- Relationship
- 10%+ Owner
- Address
- 320 N. SANGAMON, SUITE 1200, CHICAGO
- Signature
- Valor Equity Associates IV L.P., By: Valor Equity Capital IV LLC, its general partner, By: Valor Management L.P., its managing member, By: /s/ Antonio Gracias, CEO
- Signature date
- 02 Sep 2025
CIK 0001705506
VALOR EQUITY PARTNERS IV L.P.
- Relationship
- 10%+ Owner
- Address
- 320 N. SANGAMON, SUITE 1200, CHICAGO
- Signature
- Valor Equity Partners IV, L.P., By: Valor Equity Associates IV L.P., By: Valor Equity Capital IV LLC, its general partner, By: Valor Management L.P., its managing member, By: /s/ Antonio Gracias, CEO
- Signature date
- 02 Sep 2025
CIK 0001705542
VALOR EQUITY PARTNERS IV-A L.P.
- Relationship
- 10%+ Owner
- Address
- 320 N. SANGAMON, SUITE 1200, CHICAGO
- Signature
- Valor Equity Partners IV-A, L.P., By: Valor Equity Associates IV L.P., By: Valor Equity Capital IV LLC, its general partner, By: Valor Management L.P., its managing member, By: /s/ Antonio Gracias, CEO
- Signature date
- 02 Sep 2025
CIK 0001705512
VALOR EQUITY PARTNERS IV-B L.P.
- Relationship
- 10%+ Owner
- Address
- 320 N. SANGAMON, SUITE 1200, CHICAGO
- Signature
- Valor Equity Partners IV-B, L.P., By: Valor Equity Associates IV L.P., By: Valor Equity Capital IV LLC, its general partner, By: Valor Management L.P., its managing member, By: /s/ Antonio Gracias, CEO
- Signature date
- 02 Sep 2025
CIK 0001495158
Gracias Antonio J.
- Relationship
- Director, 10%+ Owner
- Address
- C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING
- Signature
- /s/ Antonio Gracias
- Signature date
- 02 Sep 2025
CIK 0001821210
Sabater Juan A.
- Relationship
- Director, 10%+ Owner
- Address
- 630 W. GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING
- Signature
- /s/ Juan A. Sabater
- Signature date
- 02 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HRMY
transaction
Common Stock
Other
- Transaction value
- Shares
- -6,618,033
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Aug 2025
- Ownership
- Direct
- Footnotes
- F1
HRMY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 29,497
- Date
- 28 Aug 2025
- Ownership
- See Footnote
- Footnotes
- F2, F3
HRMY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 437,619
- Date
- 28 Aug 2025
- Ownership
- See Footnote
- Footnotes
- F2, F4
HRMY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,423
- Date
- 28 Aug 2025
- Ownership
- See Footnote
- Footnotes
- F2, F5
HRMY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 38,275
- Date
- 28 Aug 2025
- Ownership
- See Footnote
- Footnotes
- F2, F6
HRMY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 23,714
- Date
- 28 Aug 2025
- Ownership
- See Footnote
- Footnotes
- F2, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
In-kind pro rata distribution by Valor IV Pharma Holdings, LLC, without consideration.
Footnote F2
Shares received in distribution described in footnote 1.
Footnote F3
Held by Valor Management L.P.
Footnote F4
Held by Antonio Gracias.
Footnote F5
Held by AJG Growth Fund LLC, an entity controlled by Mr. Gracias.
Footnote F6
Held by Juan Sabater.
Footnote F7
Held by Tamal, LLC, an entity controlled by Mr. Sabater.
SEC remarks
Valor Funds Group LLC is the general partner of Valor Management L.P., which is the managing member of Valor Equity Capital IV LLC, which is the general partner of Valor Equity Associates IV L.P., which, in turn, is the general partner of limited partnerships (Valor Equity Partners IV L.P, Valor Equity Partners IV-A L.P. and Valor Equity Partners IV-B L.P.) that are the members of Valor IV Pharma Holdings, LLC. Antonio Gracias and Juan Sabater, each of whom is a director of the Issuer, may each be deemed to share beneficial ownership over the shares of the Issuer held by Valor IV Pharma Holdings, LLC by virtue of their positions with the above Valor entities; however, each disclaims beneficial ownership of the shares held by Valor IV Pharma Holdings, LLC.